Global Graves’ Disease Drug Pipeline Research Report 2023: Comprehensive Insights About 8+ Companies and 10+ Pipeline Drugs – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Graves’ Disease – Pipeline Insight, 2023” drug pipelines has been added to ResearchAndMarkets.com’s... Read more.
Desktop Metal Announces Third Quarter 2023 Financial Results
Completed $100 million in cost reductions announced in June 2022 ahead of schedule Revenue of $42.8 million compared to $47.1 million in the same quarter a year... Read more.
Global Blue Releases the Monthly Tax Free Shopping Business Update for October 2023
SIGNY, Switzerland–(BUSINESS WIRE)–New data from Global Blue (NYSE:GB) reveals that the global dynamic recovery for Tax Free Shopping has remained solid... Read more.
Superior Drilling Products Reports Third Quarter 2023 Results
Third quarter revenue was $5.1 million Strengthened international technical support group to capitalize on significant near- and long-term opportunities Creating... Read more.
Schizoaffective Disorder Drug Pipeline Research Report 2023 Featuring Lyndra Therapeutics, Luye Pharma Group, BioXcel Therapeutics, & Reviva Pharma – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Schizoaffective Disorder – Pipeline Insight, 2023” clinical trials has been added to ResearchAndMarkets.com’s... Read more.
GoodRx Reports Third Quarter 2023 Results
SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings... Read more.
FREYR Battery Reports Third Quarter 2023 Results
NEW YORK & OSLO & LUXEMBOURG–(BUSINESS WIRE)–FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation... Read more.
Fivetran Helps Dropbox Discover Business Insights
Fivetran connects 70+ data sources for cloud storage leader, improving customer experience and marketing insights OAKLAND, Calif.–(BUSINESS WIRE)–Fivetran... Read more.
Grab Reports Third Quarter 2023 Results
Revenue grew 61% year-over-year to $615 million1 Loss for the period improved by 71% year-over-year to $99 million Group Adjusted EBITDA grew to $29 million, delivering... Read more.
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research,... Read more.